Recent, but very small study from China on a possible latent (or active) TB connection here:
"To determine if latent or active TB increase susceptibility to SARS-COV-19 infection and disease severity, and lead to more rapid development of COVID-19 pneumonia." ...
"This observational study of the relationship between MTB infection and COVID-19 pneumonia suggests that individuals with latent or active TB may be more susceptible to SARS-CoV-2 infection, and that COVID-19 disease progression may be more rapid and severe."
"Given that TB causes more deaths than any other infectious disease (1.45 million deaths and 10 million new cases in 2018), and that global rates of LTBI are estimated to be as high as 25%, these findings are a cautionary reminder to clinicians that MTB infection status should be considered when treating COVID-19 patients in order to prevent rapid deterioration in patient health."
"Our data suggest that MTB infection could be a more important risk factor than the comorbidities commonly reported in epidemiological studies such as diabetes and hypertension12."
"COVID-19 and TB are both respiratory diseases. It is perhaps not surprising that chronic respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), and indeed active TB, could predispose susceptibility to SARS-CoV-2."
"The strength of this finding, however, is limited by the relatively low number of cases involved in this study and requires further validation.
Based on our findings, we make the following recommendations for the management and treatment of patients with a history of MTB infection (LTBI or active TB) and possible SARS-CoV-2 coinfection" ...
"This is the first study to date to consider MTB infection as a comorbidity for COVID-19.Going forward, it will be important to validate the relationship uncovered here among these 36 COVID-19 cases in a larger study."
www.medrxiv.org/content/10.1101/2020.03.10.20033795v1
"Latent tuberculosis infection (LTBI) is a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active TB. Someone has latent TB if they are infected with the TB bacteria but do not have signs of active TB disease and do not feel ill. However, they can develop active TB disease in the future."
Screening for latent tuberculosis in UK health care workers 2017.
Background:
"Active tuberculosis (TB) infection was diagnosed in two health care workers (HCWs) originally from high-incidence countries at a National Health Service (NHS) hospital trust in Northern England. In response, the trust screened current clinical employees from countries with a high TB prevalence for active and latent TB infection (LTBI)."
Aims:
"To identify the number of HCWs, within the organization, who are at risk of TB infection."
Methods:
"Clinical employees from countries with a high TB prevalence (those described by the World Health Organization as having an incidence of >40 cases per 100000 populations) were reviewed. Employees were identified via human resource systems and occupational health records, from which nationality or country of birth was identified. A letter was sent to identified employees advising of the rationale for a reviewed screening process and inviting them to attend for an interferon-gamma release assay (IGRA) blood test."
Results:
"A total of 587 clinical staff were identified as fitting the criteria of clinical HCWs from high-incidence countries. Of 469 HCWs screened, 27% screened positive using IGRA. This represented 4% of the total clinical workforce for the organization."
Conclusions:
"A considerable proportion of the workforce at this NHS hospital trust had previously undiagnosed LTBI, carrying a risk of conversion to active disease."
www.ncbi.nlm.nih.gov/pubmed/29016903